Dr. Dickson is Division Chief of Genetics and Genomic Medicine; and Centennial Professor of Pediatrics and Genetics in the division of Pediatrics at the Washington University School of Medicine in St. Louis. She received her bachelor’s degree in Classics from the University of Chicago, and her medical degree from Columbia University College of Physicians and Surgeons in New York. Dr. Dickson’s main research focus is intra-cerebrospinal fluid (intraventricular and intrathecal) enzyme replacement therapy (ERT) for the mucopolysaccharidoses, with the goal of finding new and better treatments for patients. Her laboratory conducts bench-to-bedside research into treatments for MPS disorders. 

Representative Publications:

Intrathecal Enzyme Replacement Therapy to Treat Spinal Cord Compression in Mucopolysaccharidosis: Overview and Rationale

Intrathecal Enzyme Replacement Therapy in a Patient With Mucopolysaccharidosis Type I and Symptomatic Spinal Cord Compression

Safety of Laronidase Delivered Into the Spinal Canal for Treatment of Cervical Stenosis in Mucopolysaccharidosis I

Insulin-Like Growth Factor II Peptide Fusion Enables Uptake and Lysosomal Delivery of α-N-Acetylglucosaminidase to Mucopolysaccharidosis Type IIIB Fibroblasts

Share

Discuss in Social Wall

Share to rareTeam

Bookmark